Overview

Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of a low dose transdermal contraceptive delivery system containing ethinyl estradiol and levonorgestrel.
Phase:
Phase 3
Details
Lead Sponsor:
Agile Therapeutics
Treatments:
Contraceptive Agents
Contraceptives, Oral
Estradiol
Ethinyl Estradiol